首页> 外文期刊>American Journal of Kidney Diseases: The official journal of the National Kidney Foundation >Obesity-related glomerulopathy in China: a case series of 90 patients.
【24h】

Obesity-related glomerulopathy in China: a case series of 90 patients.

机译:中国肥胖相关性肾小球病:90例病例。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The epidemic of obesity has been paralleled by an increase in the incidence of chronic kidney disease. However, epidemiological data for obesity-related glomerulopathy (ORG) from developing countries, including China, are very limited. STUDY DESIGN: Case series. ORG defined as body mass index (BMI) of 28.0 kg/m(2) or greater; urinary protein excretion of 0.4 g/24 h or greater, and glomerulomegaly (glomerular volume 3.27 x 10(6) microm(3)) with or without focal segmental glomerulosclerosis (FSGS). SETTING & PARTICIPANTS: 10,093 renal biopsy samples from patients obtained from February 2002 to November 2006 at the Research Institute of Nephrology, Nanjing University School of Medicine, China. PREDICTOR: Obesity defined as a BMI of 28.0 kg/m(2) or greater. Subjects were divided into 3 groups: mild-obesity group with BMI of 28.0 to less than 30 kg/m(2), moderate-obesity group with BMI of 30 to less than 35 kg/m(2), and severe-obesity group with BMI of 35 kg/m(2) or greater. OUTCOMES & MEASUREMENTS: Clinicoepidemiological and histopathologic characteristics of patients with ORG at the time of biopsy were described separately. RESULTS: ORG was observed in 90 biopsy specimens (0.89%); frequency increased from 0.62% to 1.0% during the last 5 years (P = 0.02). Mean age was 37.5 +/- 9.3 (SD) years, 67% were men, mean BMI was 31.2 +/- 3.3 kg/m(2), waist circumference was 103 cm (range, 89.4 to 124 cm) in men and 96.5 cm (range, 88.5 to 113 cm) in women, waist-hip ratio was 0.95 +/- 0.07, and 100% had visceral obesity. Of the total, 49%, 37%, and 14% had mild, moderate, and severe obesity, respectively. Mean urinary protein excretion of subjects was 1.48 +/- 1.2 g/24 h; 51%, 39%, and 10% had proteinuria with protein of 0.4 to 1.0, 1.0 to 3.5, and greater than 3.5 g/d, respectively. Mean measured creatinine clearance (Ccr) was 109 +/- 32.2 mL/min/1.73 m(2), with 42%, 36%, and 22% with a Ccr greater than 120, 90 to 120, and less than 90 mL/min/1.73 m(2), respectively. Glucose dysmetabolism, insulin resistance, dyslipidemia, and hypertension were observed in 77%, 88%, 76%, and 63% of patients, respectively. FSGS was observed in 70%. Mean foot-process width was 534 +/- 176 nm. Foot-process fusion was seen in 36% of patients. Greater BMI was associated with greater proteinuria (P 0.02), greater Ccr (P 0.03), and greater foot-process width (P 0.04). LIMITATIONS: Inability to compute prevalence or incidence from case series. BMI was calculated at time of renal biopsy. CONCLUSIONS: Most patients with ORG had mild obesity, visceral obesity, minor proteinuria, preserved Ccr, and FSGS.
机译:背景:肥胖的流行与慢性肾脏疾病的发生率增加同时发生。但是,来自包括中国在内的发展中国家的肥胖相关性肾小球病(ORG)的流行病学数据非常有限。研究设计:案例系列。 ORG定义为28.0 kg / m(2)或更高的体重指数(BMI);尿蛋白排泄量为0.4 g / 24 h或更长,并伴或不伴局灶性节段性肾小球硬化(FSGS)的肾小球肿大(肾小球体积> 3.27 x 10(6)microm(3))。单位与参与者:2002年2月至2006年11月在南京大学医学院附属肾脏病研究所获得的10,093例肾活检样本。预测:肥胖定义为BMI为28.0 kg / m(2)或更高。受试者分为3组:BMI为28.0至30 kg / m 2的轻度肥胖组(2),BMI 30至35 kg / m 2的轻度肥胖组(2)和重度肥胖组BMI为35 kg / m(2)或更高。结果与测量:活检时ORG患者的临床流行病学和组织病理学特征分别描述。结果:在90例活检标本中观察到了ORG(占0.89%)。在过去5年中,该频率从0.62%增加到1.0%(P = 0.02)。平均年龄为37.5 +/- 9.3(SD)岁,男性为67%,平均BMI为31.2 +/- 3.3 kg / m(2),男性腰围为103厘米(范围89.4至124厘米),男性为96.5女性的腰围(88.5至113厘米),腰臀比为0.95 +/- 0.07,内脏肥胖为100%。在总数中,分别有49%,37%和14%患有轻度,中度和重度肥胖。受试者的平均尿蛋白排泄为1.48 +/- 1.2 g / 24 h; 51%,39%和10%的人患有蛋白尿,蛋白质分别为0.4至1.0、1.0至3.5和大于3.5 g / d。测得的肌酐平均清除率(Ccr)为109 +/- 32.2 mL / min / 1.73 m(2),Ccr大于120、90至120和小于90 mL /时分别为42%,36%和22% min / 1.73 m(2)。分别在77%,88%,76%和63%的患者中观察到了葡萄糖代谢异常,胰岛素抵抗,血脂异常和高血压。观察到FSGS的占70%。平均足突宽度为534 +/- 176nm。 36%的患者可见足突融合。较高的BMI与较高的蛋白尿(P <0.02),较高的Ccr(P <0.03)和较大的足突宽度(P <0.04)有关。局限性:无法从病例系列中计算患病率或发病率。在肾活检时计算BMI。结论:大多数ORG患者患有轻度肥胖,内脏肥胖,轻度蛋白尿,保留的Ccr和FSGS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号